Key Insights

Highlights

Success Rate

93% trial completion (above average)

Published Results

762 trials with published results (21%)

Research Maturity

2596 completed trials (71% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

5.2%

189 terminated out of 3631 trials

Success Rate

93.2%

+6.7% vs benchmark

Late-Stage Pipeline

27%

991 trials in Phase 3/4

Results Transparency

29%

762 of 2596 completed with results

Key Signals

762 with results93% success189 terminated

Data Visualizations

Phase Distribution

2,945Total
Not Applicable (1217)
Early P 1 (18)
P 1 (414)
P 2 (305)
P 3 (547)
P 4 (444)

Trial Status

Completed2,596
Unknown367
Recruiting213
Terminated189
Active Not Recruiting86
Withdrawn72

Trial Success Rate

93.2%

Benchmark: 86.6%

Based on 2596 completed trials

Clinical Trials (3631)

Showing 20 of 20 trials
NCT07112339Phase 4RecruitingPrimary

A Research Study to See How Well Weekly Insulin Icodec Maintains Blood Sugar Levels Compared to Daily Basal Insulins in Adults With Type 2 Diabetes

NCT05882071Active Not RecruitingPrimary

Non-interventional Study (NIS) on Sodium-glucose Co-transporter-2 Inhibitors (SGLT2i) Use in France

NCT00391027Phase 4CompletedPrimary

A Clinical Trial Comparing the Efficacy and Safety of Exubera® and Lantus®

NCT04760626Phase 3CompletedPrimary

A Research Study to Compare a New Weekly Insulin, Insulin Icodec Used With DoseGuide App, and Daily Insulins in People With Type 2 Diabetes Who Have Not Used Insulin Before

NCT07757464Phase 1Not Yet RecruitingPrimary

Pre-emptive Insulin to Prevent High Glucose After a Knee Steroid Injection in Adults With Type 2 Diabetes

NCT00418522Phase 4CompletedPrimary

This Study Is To Determine If Inhaled Insulin Is Effective In Treating Type 2 Diabetes Mellitus

NCT06329375Not ApplicableRecruitingPrimary

Food Insecurity Reduction & Strategy Team

NCT07415954Phase 2RecruitingPrimary

A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes

NCT07668388Phase 2RecruitingPrimary

A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes

NCT05035082Phase 4CompletedPrimary

A Research Study Comparing RYBELSUS® to Other Blood Sugar Lowering Tablets in People Living in America With Type 2 Diabetes (REALYSE)

NCT06205030Phase 4CompletedPrimary

Efficacy of NOSHINtrial in Diabetic Patients

NCT02896140CompletedPrimary

Effect of Dairy Consumption on Glycemic Control, Body Weight and Cardiovascular Risk Factors

NCT04284943Not ApplicableRecruiting

Surgical TreAtment for Obesity Related Disease and Onco-Metabolic Surgery

NCT07064473Phase 3RecruitingPrimary

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

NCT05370781Not ApplicableCompletedPrimary

Michigan Men's Diabetes Project 2

NCT06493955Not ApplicableNot Yet RecruitingPrimary

Evaluation of the Effectiveness of Extending the "Passerelle" System for Prescribing Adapted Physical Activity to Patients With Type 2 Diabetes in Nouvelle-AQUItaine (France)

NCT05984238Not ApplicableCompletedPrimary

A Trial to Evaluate Safety, Feasibility and Efficacy of Endoscopic Duodenal PEF Therapy

NCT06571474Recruiting

Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity (ATM)

NCT06092476Not ApplicableActive Not RecruitingPrimary

Trial to Evaluate Efficacy+Safety of Revita DMR Treatment Paradigm 1 and Retreatment in Type 2 Diabetes Patients

NCT06066528Phase 3Completed

A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who Also Have Diabetes to Lose Weight

Scroll to load more

Research Network

Activity Timeline